GTC Biotherapeutics (fka GTCB)

[OKY]

Just noticed our analyst friends -

I see that the analysis, all two of them, say this year
GTC will lose .48c and next year GTC will lose .39c with
a revenue increase of only 4 million. Can't be, although
my memory fails me at times I recall a much higher revenue
figure for next year.

I don’t get this? Then they say the 12 month potential
is $4.00 per share? Based on their increased revenue
figures I don't see how.

Can someone tell me the potential income from Europe
alone? Also increased expense figures due
to distribution and goat food etc. if available.

OKY